Navigation Links
Sinovac Reports Unaudited Third Quarter 2013 Financial Results
Date:11/12/2013

al and administrative expenses for the first nine months of 2013 were $24.6 million, compared to $18.9 million in the same period of 2012. Selling expenses as a percentage of 2013 nine months regular product sales was 31.6%, compared to 33.5% of the same period of last year. The decrease in selling expense as a percentage of regular product sales was mainly due to the higher sales achieved without significantly increasing the sales team headcount and salaries. G&A expenses in the first nine months of 2013 increased to $10.0 million from $8.9 million in the same period of last year. The factors affecting general and administrative expenses in the nine months of 2013 were the same as for the third quarter of 2013 as described above.

Research and development expenses for the first nine months of 2013 decreased to $5.9 million from $15.8 million in the same period of last year as the phase III study of EV71 vaccine candidate was completed in the first quarter of 2013.

Depreciation of property, plant and equipment and amortization of licenses, permits and renovation costs in the first nine months of 2013 was $2.1 million, compared to $1.1 million in the same period of last year. Depreciation increased because more assets at the Changping facility started to be depreciated in the last quarter of 2012.

Net income attributable to stockholders in the first nine months of 2013 was $1.6 million, or $0.03 per basic and diluted share, compared to a net loss of $10.2 million, or $0.19 per basic and diluted share, in the same period of last year. If the $1.7 million bonus, settled from an accrued liability account, was charged to operations for the nine-month period, the net loss of the first nine months of 2013 was $0.1 million, or $0.002 per basic share and diluted share.

As of September 30, 2013, cash and cash equivalents totaled $89.0 million, compared to $91.2 million as of December 31, 2012. Net cash used in operating activities was $14.7 mill
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Sinovac to Host Conference Call to Report First Quarter 2012 Unaudited Financial Results
2. Sinovac Reports Unaudited First Quarter 2012 Financial Results
3. Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
4. Sinovac Schedules 2012 Annual Meeting of Shareholders
5. Sinovac to Host Conference Call to Report Second Quarter 2012 Unaudited Financial Results
6. Sinovac Reports Unaudited Second Quarter 2012 Financial Results
7. Sinovac Holds 2012 Annual General Meeting of Shareholders
8. Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens
9. Sinovac to Host Conference Call to Report Third Quarter 2012 Unaudited Financial Results
10. Sinovac Reports Unaudited Third Quarter 2012 Financial Results
11. Sinovac EV71 Vaccine Phase III Top-Line Results Presented at 13th Annual World Vaccine Congress & Expo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 28, 2014  Seres Health, a clinical-stage therapeutics ... the human microbiome, announced today that Dr. ... R&D and Chief Scientific Officer, will be presenting ... and Chemotherapy (ICAAC). The presentation will highlight the ... mixture of bacterial spores derived from the human ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- Gateway ... at the 9 th Annual Global Pharma ... , September 8-9 th . The Global Pharma ... leaders in small molecule and biologic pharmaceutical manufacturing. ... challenges that today,s manufacturers face, such as the ...
(Date:8/28/2014)... 28, 2014 Reportlinker.com announces ... is available in its catalogue: ... Markets to 2020 - Novel Therapeutic ... Newly Diagnosed and Recurrent GBM ... Glioblastoma Multiforme Therapeutics in ...
Breaking Medicine Technology:Seres Health to Present Clinical Findings at ICAAC 2014 Conference 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 2Gateway Analytical to Promote Particulate Identification Services at the 9th Annual Global Pharma Manufacturing Summit 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 2Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 3Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 4Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 5Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 6Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 7Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 8Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM 9
... HAYWARD, Calif., Oct. 27, 2011  Questcor Pharmaceuticals, Inc. (NASDAQ: ... partnering with the Child Neurology Foundation (CNF) in support ... which will take place October 24-30, 2011, in conjunction ... Savannah, Georgia. As part of this education ...
... Inland Northwest Health Services (INHS), one of ... collaboration with Science Applications International Corporation (SAIC) (NYSE: ... enabling the secure exchange of electronic health information ... part of the Electronic Disability Benefits Eligibility Determination ...
Cached Medicine Technology:Questcor and Child Neurology Foundation Support the 3rd Annual Infantile Spasms (IS) Awareness Week 2Questcor and Child Neurology Foundation Support the 3rd Annual Infantile Spasms (IS) Awareness Week 3Questcor and Child Neurology Foundation Support the 3rd Annual Infantile Spasms (IS) Awareness Week 4
(Date:8/28/2014)... problem in winemaking is "stuck fermentation," when yeast that ... carbon dioxide prematurely shuts down, leaving the remaining sugar ... the wine. , A team of researchers including UC ... communication system behind this problem. Working through a ... itself -- the system enables bacteria in fermenting wine ...
(Date:8/28/2014)... Data from the American Hospital Association’s 2013 Annual ... a basic electronic health record (EHR) system, more advanced ... challenge. , This data is featured in an ... , and is co-authored by Peter Kralovec, executive director ... as Chantal Worzala, director for policy at the AHA. ...
(Date:8/28/2014)... Tenn. The New England Journal of Medicine ... clinical trial of a drug shown to safely reduce ... volunteers intranasally infected with respiratory syncytial virus (RSV). ... of Tennessee Health Science Center researcher Infectious Disease Specialist ... , RSV is the most common cause ...
(Date:8/28/2014)... hurting reproduction of the endangered Devils Hole pupfish, threatening the ... as 35 individuals, new research by the University of Nevada, ... geothermal water on a small shelf near the surface of ... live is heating up as a result of climate change ... , The hotter water, which now reaches more than 93 ...
(Date:8/28/2014)... GABLES, Fla (Aug. 26, 2014)-- Cigarette smoking kills ... Centers for Disease Control and Protection. It,s the ... to overcome this addiction, many people resort to ... review study by researchers at the University of ... found in cigarette substitutes could be harmful to ...
Breaking Medicine News(10 mins):Health News:Prions can trigger 'stuck' wine fermentations, researchers find 2Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 2Health News:AHA Data Shows Progress, Challenges on Road to Healthcare IT Adoption 3Health News:DeVincenzo study breakthrough in RSV research 2Health News:Climate change puts endangered Devils Hole pupfish at risk of extinction 2Health News:Climate change puts endangered Devils Hole pupfish at risk of extinction 3Health News:Are cigarette substitutes a safe alternative? It depends on user habits 2Health News:Are cigarette substitutes a safe alternative? It depends on user habits 3
... expect from a wine.It's important to know how I plan to ... Federal Association of German Wine Cellars and Wine Sales, here. ... accompany a meal or is to be enjoyed with a good ... what to drink. A shopper has to decide whether they prefer ...
... Researchers at the University Of Pennsylvania School Of Medicine ... virus (EBV) protein and a vital cancer pathway earlier ... research and have found that the viral protein, named ... ,This protein is very necessary in controlling cell ...
... Ranjan Dasmunsi, Information and Broadcasting Minister said that Dr. Manmohan ... join the International Agency// for Research on Cancer (IARC). ... in the country. This membership will help in the development ... environmental risk factors and facilitate the development of initial preventive ...
... in our ancestors, they gave more gifts to the ... habit of exchanging gifts and foods between// them which ... Gurven, University of California said, "Reciprocity is arguably the ... feature of reciprocity is the contingent relationship between acts ...
... between Apollo Hospitals and the Stanford Emergency Medicine ... of a first-ever international programme for training of ... time programme would be conducted at Apollo Hospitals, ... or an equivalent examination are eligible to enroll ...
... Becares, Ph.D, student at Public University of Navarre has ... found to have anti-cancer effects//. She tested 24 compounds ... it had antitumor activity when tested in invitro cell ... have antitumor activity and she feels that still a ...
Cached Medicine News:Health News:Festive Tip For Wine Shoppers 2
Stainless steel. Lamp is in fiberoptic handle. Green color coding. The blade includes a port that permits delivery of oxygen or other gas mixtures during intubation....
... of the vocal cords in even the most ... like a standard laryngoscope, Viewmax® does not require ... its ability to allow intubation whether you are ... airway. It has a patented lens system that ...
... Stainless steel. Lamp supplied with ... operate on any standard/conventional handle allowing ... illumination without the potential confusion from ... blades offer an easy and cost ...
... The FR-120F, Fujinon's new fiberoptic Naso-Pharyngo-Laryngoscope provides ... patient comfort. The latest in Fujinon ... increased light guide, and a wide 90 ... impressive 3.3mm distal tip diameter. In ...
Medicine Products: